Relevant bibliographies by topics / Pilates ; Multiple Sclerosis ; Clinical Trial

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters

Academic literature on the topic 'Pilates ; Multiple Sclerosis ; Clinical Trial'

Author: Grafiati
Published: 4 June 2021
Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pilates ; Multiple Sclerosis ; Clinical Trial.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pilates ; Multiple Sclerosis ; Clinical Trial"

1

Küçük, Fadime, Bilge Kara, Esra Çoşkuner Poyraz, and Egemen İdiman. "Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial." Journal of Physical Therapy Science 28, no. 3 (2016): 761–68. http://dx.doi.org/10.1589/jpts.28.761.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Abasıyanık, Zuhal, Özge Ertekin, Turhan Kahraman, Pınar Yigit, and Serkan Özakbaş. "The effects of Clinical Pilates training on walking, balance, fall risk, respiratory, and cognitive functions in persons with multiple sclerosis: A randomized controlled trial." EXPLORE 16, no. 1 (2020): 12–20. http://dx.doi.org/10.1016/j.explore.2019.07.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Duff, Whitney R. D., Justin W. Andrushko, Doug W. Renshaw, et al. "Impact of Pilates Exercise in Multiple Sclerosis." International Journal of MS Care 20, no. 2 (2018): 92–100. http://dx.doi.org/10.7224/1537-2073.2017-066.

Full text
Abstract:
CME/CNE Information Activity Available Online: To access the article, post-test, and evaluation online, go to http://www.cmscscholar.org Target Audience: The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives: Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the A
APA, Harvard, Vancouver, ISO, and other styles
4

Fox, Esther E., Alan D. Hough, Siobhan Creanor, Margaret Gear, and Jennifer A. Freeman. "Effects of Pilates-Based Core Stability Training in Ambulant People With Multiple Sclerosis: Multicenter, Assessor-Blinded, Randomized Controlled Trial." Physical Therapy 96, no. 8 (2016): 1170–78. http://dx.doi.org/10.2522/ptj.20150166.

Full text
Abstract:
Abstract Background Pilates exercise is often undertaken by people with multiple sclerosis (MS) who have balance and mobility difficulties. Objectives The primary aim of the study was to compare the effects of 12 weeks of Pilates exercises with relaxation on balance and mobility. Secondary aims were: (1) to compare standardized exercises with relaxation and (2) to compare Pilates exercises with standardized exercises. Methods A multicenter, assessor-blinded, randomized controlled trial was conducted. Participants with Expanded Disability Status Scale scores of 4.0 to 6.5 were randomly allocate
APA, Harvard, Vancouver, ISO, and other styles
5

De Gasperis-Brigante, C. D., J. L. Parker, P. W. O’Connor, and T. R. Bruno. "Reducing clinical trial risk in multiple sclerosis." Multiple Sclerosis and Related Disorders 5 (January 2016): 81–88. http://dx.doi.org/10.1016/j.msard.2015.11.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Burton, Jodie M., and Paul O'Connor. "MULTIPLE SCLEROSIS CLINICAL TRIAL DESIGN AND ANALYSIS." CONTINUUM: Lifelong Learning in Neurology 10 (December 2004): 173–96. http://dx.doi.org/10.1212/01.con.0000293632.77732.a8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bulguroglu, I., A. Guclu-Gunduz, G. Yazici, et al. "The effects of Mat Pilates and Reformer Pilates in patients with Multiple Sclerosis: A randomized controlled study." NeuroRehabilitation 41, no. 2 (2017): 413–22. http://dx.doi.org/10.3233/nre-162121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sánchez-Lastra, Miguel A., Daniel Martínez-Aldao, Antonio J. Molina, and Carlos Ayán. "Pilates for people with multiple sclerosis: A systematic review and meta-analysis." Multiple Sclerosis and Related Disorders 28 (February 2019): 199–212. http://dx.doi.org/10.1016/j.msard.2019.01.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Greenstein, Jeffrey I. "Problems in Clinical Trial Design in Multiple Sclerosis." International Journal of MS Care 4, no. 3 (2002): 125–38. http://dx.doi.org/10.7224/1537-2073-4.3.125.

Full text
Abstract:
Historically, it has been difficult to demonstrate the effectiveness of treatments for multiple sclerosis (MS) because of the variability in the course of the disease, the lack of well-defined, reliable clinical measures, and the pervasiveness of poorly controlled clinical trials. Hence, to interpret the results of clinical trials in MS and make evidence-based decisions regarding treatment for their patients, neurologists should have a basic understanding of appropriate outcome measures and the necessary controls of a well-designed study. This paper reviews the controls required to test the ef
APA, Harvard, Vancouver, ISO, and other styles
10

Moneim, Joseph, Alasdair Coles, Gavin Giovannoni, Rachel Horne, and Oliver Carr. "Women on multiple sclerosis clinical trial steering committees." Annals of Neurology 84, no. 2 (2018): 329–30. http://dx.doi.org/10.1002/ana.25306.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pilates ; Multiple Sclerosis ; Clinical Trial"

1

Fox, Esther Elizabeth. "The effects of pilates based core stability training in people with MS." Thesis, University of Plymouth, 2015. http://hdl.handle.net/10026.1/3477.

Full text
Abstract:
Background: People with Multiple Sclerosis experience difficulties with balance and mobility. Pilates exercises are often used to address these difficulties. Design: This was a multi-centre, double blind, block randomised, controlled trial. Eligible participants were recruited from seven UK centres. Participants were randomly allocated to either: Pilates based core stability training (Pilates), Standardised Exercise (SE) or Relaxation (placebo). All received face-to-face training sessions over a 12 week period; together with a home exercise programme. Blinded assessments were taken before trai
APA, Harvard, Vancouver, ISO, and other styles
2

Turcotte, Dana. "Multiple sclerosis-induced neuropathic pain." The Consultant Pharmacist, 2004. http://hdl.handle.net/1993/23316.

Full text
Abstract:
Neuropathic pain (NPP) is a chronic syndrome suffered by patients with multiple sclerosis (MS), for which there is no cure. Underlying cellular mechanisms involved in its pathogenesis are multifaceted, resulting in significant challenges in its management. In addition to its complex pathophysiology, the clinical management of MS-induced NPP is further complicated by the lack of clinical therapeutics trials specific to this population. The primary aim of the work underlying this thesis was to contribute to the evidence-based management of individuals with MS-induced NPP through the completion o
APA, Harvard, Vancouver, ISO, and other styles
3

Riddell, Corinne Aileen. "An adaptive clinical trial design for a sensitive subgroup examined in the multiple sclerosis context." Thesis, University of British Columbia, 2011. http://hdl.handle.net/2429/33818.

Full text
Abstract:
Adaptive clinical trials are recently gaining more attention. In this thesis, generalizations to the Biomarker-Adaptive Threshold Design (BATD) are studied and applied in the multiple sclerosis (MS) context. The BATD was originally developed for survival outcomes for Phase III clinical trials and allows researchers to both study the efficacy of treatment in the overall group and to investigate the relationship between a hypothesized predictive biomarker and the treatment effect on the primary outcome. We first introduce the original methodology and replicate the authors’ simulation studies to
APA, Harvard, Vancouver, ISO, and other styles
4

Schirda, Brittney Leigh. "Mindfulness Training and Impact on Emotion Dysregulation and Strategy Use in Multiple Sclerosis: A Pilot, Placebo-controlled, Randomized Controlled Trial." The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1565705935451238.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ziemssen, Tjalf, and Katja Thomas. "Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world." Sage, 2017. https://tud.qucosa.de/id/qucosa%3A35541.

Full text
Abstract:
Alemtuzumab is a humanized monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS), given as two annual courses on five consecutive days at baseline and on three consecutive days 12 months later. Here we provide an update on the long-term efficacy and safety of alemtuzumab in RRMS, including realworld experience, and advances in our understanding of its mechanism of action. Recent data from the phase II/III extension study have demonstrated that alemtuzumab reduces relapse rates, disability worsening, and the rate of brain volume loss over the long term,
APA, Harvard, Vancouver, ISO, and other styles
6

Rossman, Ian. "OPTICAL COHERENCE TOMOGRAPHY TO MEASURE EFFECTS OF AUTOLOGOUS MESENCHYMAL STEM CELL TRANSPLANT IN MULTIPLE SCLEROSIS PATIENTS." Case Western Reserve University School of Graduate Studies / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=case1486132609814919.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

D’yachkova, Yulia. "Analysis of longitudinal data from the betaseron multiple sclerosis clinical trial." Thesis, 1997. http://hdl.handle.net/2429/6342.

Full text
Abstract:
Longitudinal data sets consist of repeated observations for each subject over time; and often a corresponding set of covariates is available. Analysis of longitudinal data is often based on summaries over time. Summarizing the data allows one to use simple techniques for analysis but does not allow analysis of the patterns over time and does not take advantage of the within subject information. In many fields, repeated measures analysis of variance and multivariate analysis of variance are commonly used to analyze longitudinal data on continuous responses. Such analyses are appropriate o
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Pilates ; Multiple Sclerosis ; Clinical Trial"

1

Rudick, Richard A., and Donald E. Goodkin. Treatment of Multiple Sclerosis: Trial Design, Results, and Future Perspectives. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

A, Rudick Richard, and Goodkin Donald E. 1946-, eds. Treatment of multiple sclerosis: Trial design, results, and future perspectives. Springer-Verlag, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1946-, Goodkin Donald E., and Rudick Richard A, eds. Multiple sclerosis: Advances in clinical trial design, treatment, and future perspectives. Springer, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

(Editor), Donald E. Goodkin, and Richard A. Rudick (Editor), eds. Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives. Springer, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

(Editor), Donald E. Goodkin, and Richard A. Rudick (Editor), eds. Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives. Springer, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rudick, Richard A. Treatment of Multiple Sclerosis: Trial Design, Results, and Future Perspectives (Clinical Medicine and the Nervous System). Springer-Verlag Telos, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Krieger, Stephen, Ilana Katz Sand, Svenja Oynhausen, and Aaron Miller. Issues in the Design and Interpretation of Multiple Sclerosis Clinical Trials. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199341016.003.0031.

Full text
Abstract:
This chapter covers important historical, scientific, and current issues in the development of modern clinical trials as well as therapeutic interventions for patients with multiple sclerosis. The chapter includes a review of terminology, methodology, and outcomes employed in clinical trials related to multiple sclerosis. A focus of the chapter is on the limitations of historical and current trial designs, particularly in regard to their application to clinical decision making. This second edition incorporates findings from clinical trials of oral agents and monoclonal antibodies developed for
APA, Harvard, Vancouver, ISO, and other styles
8

Beh, Shin C., Elliot M. Frohman, and Teresa Frohman. Neuro-ophthalmologic Manifestations of Multiple Sclerosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199341016.003.0012.

Full text
Abstract:
The inflammatory, demyelinating plaques that characterize multiple sclerosis (MS) frequently affect the visual pathways. Lesions of the afferent visual pathway (most commonly optic neuritis) result in problems conveying visual stimuli from the retina to the visual cortices. Lesions affecting the efferent visual system result in ocular dysmotility that impairs visual acuity by disrupting the precision of binocular eye movements or by causing excessive eye movements that prevent adequate foveation (e.g. nystagmus, saccadic intrusions). Significant advancements have been made in the techniques us
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Pilates ; Multiple Sclerosis ; Clinical Trial"

1

Ellison, George W. "Recent Advances and Future Challenges in Multiple Sclerosis Clinical Trial Design." In Multiple Sclerosis. Springer London, 1996. http://dx.doi.org/10.1007/978-1-4471-1271-6_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Grossman, Robert I. "Magnetic Resonance Imaging: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design." In Multiple Sclerosis. Springer London, 1996. http://dx.doi.org/10.1007/978-1-4471-1271-6_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

LaRocca, Nicholas G., Paul G. Ritvo, Deborah M. Miller, Jill S. Fischer, Howard Andrews, and Donald W. Paty. "“Quality of Life” Assessment in Multiple Sclerosis Clinical Trials: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design." In Multiple Sclerosis. Springer London, 1996. http://dx.doi.org/10.1007/978-1-4471-1271-6_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fischer, Jill S. "Use of Neuropsychologic Outcome Measures in Multiple Sclerosis Clinical Trials: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design." In Multiple Sclerosis. Springer London, 1996. http://dx.doi.org/10.1007/978-1-4471-1271-6_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wolinsky, J. S., P. A. Narayana, and R. He. "Overview of Treatment Trials: Early Baseline Clinical and MRI Data of the PROMiSe Trial." In Primary Progressive Multiple Sclerosis. Springer Milan, 2002. http://dx.doi.org/10.1007/978-88-470-2234-8_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gandolfi, M., N. Valè, E. Dimitrova, et al. "High-Intensity Robot-Assisted Hand Training in Individuals with Multiple Sclerosis: A Randomized, Controlled, Single-Blinded Trial." In Converging Clinical and Engineering Research on Neurorehabilitation III. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-030-01845-0_106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Clinical trial logistics Steven R Schwid." In Multiple Sclerosis Therapeutics. CRC Press, 2007. http://dx.doi.org/10.3109/9780203012055-23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"The negative clinical trial: failure or opportunity?" In Multiple Sclerosis Therapeutics. CRC Press, 1999. http://dx.doi.org/10.1201/9781439812242-28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"The failed clinical trial in multiple sclerosis." In Multiple Sclerosis Therapeutics. CRC Press, 2019. http://dx.doi.org/10.3109/9780203639115-27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"Aspects of multiple sclerosis that relate to trial design and clinical management." In Multiple Sclerosis Therapeutics. CRC Press, 2007. http://dx.doi.org/10.3109/9780203012055-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pilates ; Multiple Sclerosis ; Clinical Trial' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography